♻️ PCT: $1.13M of In-the-Money Puts Bought Into an Empty Calendar

📅 2026-08-13 | 🤝 Block Cross Detected

---

🎯 The Quick Take

At 12:34:49 ET a desk bought 8,300 September $8 puts at $1.36 in PureCycle — ≈$1.13 million, against prior open interest of just 30 contracts. A provably new position, and essentially the entire day's volume in that contract.

Unlike most put buying, this strike is already in the money. With the stock at $7.14, the $8 put carries $0.86 of intrinsic value — the buyer is paying $0.50 of time value on top, roughly 7% of the share price, for five weeks.

And there is nothing on the calendar. Q2 already reported on August 6, a week before this trade. Q3 is estimated at early November — seven weeks after expiry. Whatever this buyer expects, it is not a scheduled event.

---

🏢 Company Overview

PureCycle produces recycled polypropylene using a proprietary physical-separation process, sold as PureFive™ resin into packaging, textiles and industrial applications. It is an early-commercialisation company — revenue exists, but it is tiny relative to the valuation.

The scale problem in one line: a $1.44B market capitalisation against $13.76M of trailing revenue is ≈105× sales, on a business burning −$212.25M of free cash flow with a gross margin of −788%. Debt of $497.67M exceeds cash of $224.82M. This is a capital-intensive story where financing risk, not demand, has historically driven the share price.

Sources: PCT overview · PCT financials

---

💰 The Trade, in Plain English

The price decomposes like this:

Printed as a negotiated block cross — a known counterparty, no urgency signature, no liquidity taken. The BUY label is reported rather than tape-proven, though with 30 contracts outstanding against 8,300 traded, the opening is not in question.

---

✅ RESOLVED — Opened in Full

Updated 2026-08-14 pre-market. Resolving OPRA snapshot timestamped August 14 (reflects the August 13 close, after this print); baseline is the August 13 snapshot (reflects the August 12 close, before this print).

Contract for contract. The $8 line went from 30 to 8,327 — the print created essentially all of it, with nothing matching against existing holders. The opening read is now proven rather than inferred.

Still not proven: whether this insures shares held elsewhere or expresses a standalone bearish view. Open interest settles new versus old, never hedge versus bet.

---

🤓 What This Actually Means — Plain English

Buying an in-the-money put is different from the usual out-of-the-money bet, and it is worth understanding why someone chooses it.

An out-of-the-money put is cheap and pays only on a large move. An in-the-money put like this one already has real value — $0.86 of it — and moves more closely with the stock. You pay more, but you own something with substance rather than a lottery ticket.

What it costs here: $1.36 a share, of which $0.50 is the time-value premium — about 7% of the share price for five weeks of protection. That is expensive, and it reflects genuinely high implied volatility in this name.

What it takes to work: the stock must fall below $6.64, a further 7% decline, before the buyer profits at expiry. Below that the put gains roughly dollar-for-dollar.

Two readings we cannot separate: this is either insurance on an existing shareholding, or a directional bet on further decline. The size is substantial relative to the company — ≈$1.13M of premium controlling 830,000 shares, against a $1.44B market cap — so either way it represents a considered position rather than a casual one.

---

📈 Technical Setup

One-Year Performance

The stock trades at $7.19 against a 52-week range of $4.93 to $15.49 — closer to the low than the high, and roughly 54% below the top of that range.

🔵🟠 Gamma-Based Support & Resistance

Being honest about the chain: it produced no material gamma resistance level, and only a Moderate support at $7. We are not going to invent levels that the data does not support. A thin gamma profile is itself informative — it tells you dealer positioning is not concentrated here, so there is little structural pinning in either direction.

🎯 Implied Move

A ±27.77% expected range over five weeks is very wide, and it comfortably covers the 7% needed for breakeven. That is why the time-value component costs 7% of the share price — the market genuinely expects this stock to move.

---

🎪 Catalysts — The Window Is Empty

Nothing company-specific is scheduled inside September 18.

What Q2 actually showed (August 6): revenue $4.5M, up 173% year over year; ≈4.5 million pounds of PureFive resin produced; compounding operations ≈2.0 million pounds; total liquidity $236.9M. Commercial traction is real and improving — the absolute numbers remain very small against a $1.44B valuation.

The most important item in the last three months is a financing, not a product. On June 10 PureCycle announced concurrent public offerings of convertible senior notes AND common stock, closing June 15. A simultaneous convertible-plus-equity raise is how this company funds itself, and it is the mechanism that has repeatedly capped the shares.

The rest of the recent record is commercial and encouraging: Innovia Films BOPP film (June 9), IPL Schoeller containers (June 23 and again August 12), and a Mitsui / RM TOHCELLO partnership for flexible packaging in Japan (July 15). Full release history: PureCycle press stream.

So what could deliver the 7% fall? Not an earnings print — there isn't one. The realistic paths are unscheduled: a production or uptime setback (this name's historical pattern), another dilutive financing, a broad small-cap risk-off move, or a disappointing operational data point released outside the earnings cycle.

Keep the dates separate: the option expires September 18; the next scheduled company event is ≈November 5, and that date is an estimate.

---

👥 Four Ways to Read This Trade

🎲 The YOLO trader

An in-the-money put is not the high-convexity instrument you usually want — you are paying $1.36 for $0.86 of value that already exists. If your thesis is a sharp fall, out-of-the-money strikes give more leverage per dollar. What this trade offers instead is a position that participates immediately rather than needing a big move to come alive.

📈 The swing trader

The levels are sparse, which is itself the point — no gamma resistance and only Moderate support at $7 means little structural pinning. Against a ±27.77% implied range to September, that is a stock the market expects to travel. With no scheduled catalyst, the triggers are financing headlines and operational updates, both of which arrive without warning in this name.

💰 The premium collector

You would be the counterparty, selling an in-the-money put and taking on the obligation to buy PureCycle at $8 — an effective basis of ≈$6.64. Before you like that yield, weigh what you are underwriting: ≈105× sales, −788% gross margin, −$212M of free cash flow, and $497.67M of debt against $224.82M of cash. The elevated implied volatility here is compensating for real financing risk, not mispricing it.

🌱 The beginner

Learn the difference between the two kinds of put. An out-of-the-money put is cheap and pays only if the stock falls a lot. An in-the-money put — like this one — already has real value built in, costs more, and moves more like a short position in the stock. Neither is better; they are different tools. And notice again: there is no scheduled event inside this option's life, so nobody here is positioning for an earnings report.

---

⚠️ Honest Limits

• We cannot distinguish insurance from a bet. No equity leg appeared on the tape, but that does not rule out shares held elsewhere.
• Direction is reported, not tape-proven — the print took no liquidity. The opening is proven by size versus 30 contracts of prior open interest.
• The Q3 earnings date is a cadence estimate, not a company confirmation.
• Research gaps, and they are material on this name: the search budget was exhausted, so this rests on direct retrieval only. The Q2 press release itself returned an error and could not be read — the Q2 figures above come from the summary on the release index, so net loss, EPS, plant uptime and any guidance for the quarter are not stated here. No filings were read, so the June convertible note's size, coupon, conversion price and maturity are unknown and deliberately not stated. Any second-facility expansion could not be verified and no claim is made. No short-interest figure was retrievable.
• A share-count conflict is unresolved: the overview page reports 200.90M shares while the financials page implies ≈152.8M from trailing EPS. We use 200.90M and do not compute per-share values off the other figure.

Last updated: 2026-08-14 — next-day OPRA open interest resolved the put as an open — 30 → 8,327 (see the ✅ RESOLVED section).

This is market analysis and education, not investment advice. Options carry substantial risk of loss.